Levomefolate Calcium And Algal Recall
Get an alert when a recall is issued.
Questions & Answers
Side Effects & Adverse Reactions
Caution is recommended in patients with a family history of bipolar illness. Mood elevation is possible in this population.
Caution is also recommended in patients taking anticonvulsant medications as folate may interfere with anticonvulsant medication, and may lower seizure threshold. Furthermore, it has been reported that anticonvulsant medications interfere with folate metabolism, but the exact action is unclear; therefore caution is recommended with patients in this therapeutic group.
Patients undergoing cancer treatment should consult their licensed medical practitioner for advice.
There is currently no legal information available for this drug.
FDA Safety Alerts
There are currently no FDA safety alerts available for this drug.
There is currently no manufacturer warning information available for this drug.
FDA Labeling Changes
There are currently no FDA labeling changes available for this drug.
Levomefolate Calcium/ Algal Powder Capsules (7.5 mg-90.314 mg) are indicated for the distinct nutritional requirements of patients in need of advanced folate supplementation, specifically suboptimal L-methylfolate or maintenance-level needs, as determined by a licensed medical practitioner.
There is currently no drug history available for this drug.
Levomefolate Calcium/ Algal Powder Capsules (7.5 mg-90.314 mg) are an orally administered prescription folate-containing product specifically formulated for the dietary management of patients with unique nutritional needs requiring increased folate levels. This product should be administered under the supervision of a licensed medical practitioner.
Each capsule contains: 7.5 mg of L-Methylfolate Calcium*, 90.314 mg of Algal Powder (Schizochytrium).